CE programme
In Person

An Update on MRONJ. Prevention, Detection and Management of MRONJ in General Dental Practice

Malaysia-International Dental Exhibition and Conference, MIDEC 2024


Kuala Lumpur, Malaysia, Asia Pacific


Winnie Wing Shan Choi
  • Completed BDS, MDS and PhD at the Faculty of Dentistry, the University of Hong Kong
  • Specialist in Oral & Maxillofacial Surgery in Hong Kong since 2010
  • Has been Chief examiner in specialty board exam in Hong Kong
  • Currently works as Consultant in the Department of Dentistry and Maxillofacial Surgery at United Christian Hospital, Hong Kong
  • Practises wide scope of Maxillofacial Surgery, including Oral oncology and microvascular reconstruction, orthognathic surgery and obstructive sleep apnea, cleft and craniofacial syndromes, orofacial pain


Malaysian Dental Association

Abstract :

Medication-related osteonecrosis of the jaw (MRONJ) is associated with the use of antiresorptive agents like bisphosphonates and denosumab for treating osteoporosis and some cancers. With the increasing number of patients taking these antiresorptive agents, the incidence of MRONJ has also increased. Risk factors of MRONJ include the amount of total medication exposure, presence of dental diseases, operative dental procedures, increased age, medical co-morbidity. Dental practitioners play an important role in the prevention, detection and management of MRONJ. Strategies for managing MRONJ patients will be discussed in this lecture.

Learning objectives :

  • To learn the risk factors of MRONJ
  • To learn about the clinical manifestations and staging of MRONJ 
  • To learn about the management of MRONJ